Please use this identifier to cite or link to this item: http://hdl.handle.net/10316/28956
DC FieldValueLanguage
dc.contributor.advisorDonato, António-
dc.contributor.authorCordeiro, Steve Estêvão-
dc.date.accessioned2015-07-06T14:45:50Z-
dc.date.available2015-07-06T14:45:50Z-
dc.date.issued2015-07-06-
dc.identifier.urihttp://hdl.handle.net/10316/28956-
dc.description.abstractEvery single European citizen deserves equal opportunities to access medicines. In the last years the introduction of new technologies has exponentially increased the ability to manage some diseases, but despite of that fact, some citizens didn’t have access to these treatments. Nowadays, to choose efficiently the best options provided to citizens, a range of new health technologies’ evaluations are performed, however patients’ access throughout Europe is still different. The aim of this dissertation is to demonstrate the current status and main challenges of HTA in Europe, in order to know the European mechanisms to struggle inequality.por
dc.language.isoengpor
dc.rightsopenAccesspor
dc.subjectHealth Technology Assessment in Europepor
dc.subjectHTApor
dc.titleHealth Technology Assessment in Europe: Current Status and Main Challengespor
dc.typeother-
degois.publication.titleHealth Technology Assessment in Europe: Current Status and Challengespor
dc.peerreviewedYespor
item.fulltextCom Texto completo-
item.languageiso639-1en-
item.grantfulltextopen-
crisitem.advisor.deptFaculty of Pharmacy-
Appears in Collections:FFUC- Teses de Mestrado
Files in This Item:
File Description SizeFormat
merged.pdf5.39 MBAdobe PDFView/Open
Show simple item record

Page view(s) 20

643
checked on Oct 15, 2021

Download(s) 5

6,976
checked on Oct 15, 2021

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.